Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Katherine A Peebles, Jay M Lee, Jenny T Mao, Saswati Hazra, Karen L Reckamp, Kostyantyn Krysan, Mariam Dohadwala, Eileen L Heinrich, Tonya C Walser, Xiaoyan Cui, Felicita E Baratelli, Edward Garon, Sherven Sharma & Steven M Dubinett. (2007) Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Review of Anticancer Therapy 7:10, pages 1405-1421.
Read now
Read now
Orlando Garcia Ribeiro, Wafa Hanna Cabrera, Durvanei Augusto Maria, Marcelo De Franco, Solange Massa, Roberto Francisco Di Pace, Vinicius Ricardo Cuña de Souza, Nancy Starobinas, Michel Semen & Olga Martinez Iban˜ez. (2004) Genetic Selection For High Acute Inflammatory Response Confers Resistance To Lung Carcinogenesis In The Mouse. Experimental Lung Research 31:1, pages 105-116.
Read now
Read now
Articles from other publishers (52)
Abdullah Aslan, Yousif Taha Hussein, Ozlem Gok, Seda Beyaz, Orhan Erman & Serpil Baspinar. (2019) Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities. Environmental Science and Pollution Research 27:7, pages 7526-7537.
Crossref
Crossref
Xiaoqi Zhang, Hao Feng, Juan Du, Jing Sun, Dongfang Li, Tomoka Hasegawa, Norio Amizuka & Minqi Li. (2018) Aspirin promotes apoptosis and inhibits proliferation by blocking G0/G1 into S phase in rheumatoid arthritis fibroblast-like synoviocytes via downregulation of JAK/STAT3 and NF-κB signaling pathway. International Journal of Molecular Medicine.
Crossref
Crossref
Manuel Sarmiento Soto, Emma R. O’Brien, Kleopatra Andreou, Simon F. Scrace, Rasheed Zakaria, Michael D. Jenkinson, Eric O’Neill & Nicola R. Sibson. (2016) Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth. Oncotarget 7:32, pages 52375-52391.
Crossref
Crossref
Isabel Ben-Batalla, Miguel Cubas-Cordova, Florian Udonta, Mark Wroblewski, Jonas S. Waizenegger, Melanie Janning, Stefanie Sawall, Victoria Gensch, Lin Zhao, Iñigo Martinez-Zubiaurre, Kristoffer Riecken, Boris Fehse, Klaus Pantel, Carsten Bokemeyer & Sonja Loges. (2015) Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget 6:8, pages 6341-6358.
Crossref
Crossref
Jie Li, Liying Xue, Hongling Hao, Ruoyu Li & Jianmin Luo. (2014) Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway. Tumor Biology 35:7, pages 6467-6474.
Crossref
Crossref
Alissa Greenberg, Jun-Chieh Tsay, Kam-Meng Tchou-Wong, Anna Jorgensen & William Rom. (2013) Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials. Cancers 5:4, pages 131-148.
Crossref
Crossref
Zaher A. Radi. 2012. Comparative Pathophysiology and Toxicology of Cyclooxygenases. Comparative Pathophysiology and Toxicology of Cyclooxygenases
270
308
.
H. Mehmet Turk, Celalettin Camci, Alper Sevinc, Suleyman Bukyukberber, Ibrahim Sari & Mustafa Adli. (2012) Cyclooxygenase-2 Expression is not a Marker of Poor Survival in Lung Cancer. Asian Pacific Journal of Cancer Prevention 13:1, pages 315-318.
Crossref
Crossref
Monica M. Bertagnolli. 2012. Energy Balance and Gastrointestinal Cancer. Energy Balance and Gastrointestinal Cancer
157
182
.
Huidong Liu, Jianbing Xiao, Yanmei Yang, Yan Liu, Ruijin Ma, Yuhang Li, Fengchun Deng & Yafang Zhang. (2011) COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvascular Research 82:2, pages 131-140.
Crossref
Crossref
Hua-Chuan Zheng & Yasuo Takano. (2011) NNK-Induced Lung Tumors: A Review of Animal Model. Journal of Oncology 2011, pages 1-8.
Crossref
Crossref
Mihye Kim, Shingo Miyamoto, Yumiko Yasui, Takeru Oyama, Akira Murakami & Takuji Tanaka. (2009) Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. International Journal of Cancer 124:2, pages 264-271.
Crossref
Crossref
Sung Yong Lee, Hye Kyoung Choi, Kyoung Ju Lee, Jin Yong Jung, Gyu Young Hur, Ki Hwan Jung, Je Hyeong Kim, Chol Shin, Jae Jeong Shim, Kwang Ho In, Kyung Ho Kang & Se Hwa Yoo. (2009) The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells. Journal of Immunotherapy 32:1, pages 22-28.
Crossref
Crossref
Kin Chung Leung & George G. Chen. 2009. Apoptosis in Carcinogenesis and Chemotherapy. Apoptosis in Carcinogenesis and Chemotherapy
251
272
.
Linda M. Sargent, Mang X. Ensell, Anne-Carine Ostvold, Kimberly T. Baldwin, Michael L. Kashon, David T. Lowry, Jamie R. Senft, Amy M. Jefferson, Robert C. Johnson, Zhi Li, Frederick L. Tyson & Steven H. Reynolds. (2008) Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicology and Applied Pharmacology 233:1, pages 81-91.
Crossref
Crossref
Monica Bertagnolli, Jaye L. Viner & Ernest T. Hawk. 2008. Molecular Targeting in Oncology. Molecular Targeting in Oncology
509
541
.
David E. Williams. 2008. Advances in Bioactivation Research. Advances in Bioactivation Research
1
27
.
Sonia Hernández-Díaz & Luis A. García Rodríguez. (2007) Nonsteroidal anti-inflammatory drugs and risk of lung cancer. International Journal of Cancer 120:7, pages 1565-1572.
Crossref
Crossref
Nobuko Wakamatsu, Theodora R. devereux, Hue-Hua L. Hong & Robert C. Sills. (2016) Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer. Toxicologic Pathology 35:1, pages 75-80.
Crossref
Crossref
Samir Malhotra, Stephen Lam, SF Paul Man, Wen Q Gan & Don D Sin. (2006) The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women. BMC Pulmonary Medicine 6:1.
Crossref
Crossref
Paul B. Myrdal, B. Steven Angersbach, Kelly Karlage & Philip J. Kuehl. (2006) Chiral separation of lipoxygenase metabolites utilizing high-performance liquid chromatography. Journal of Chromatography A 1132:1-2, pages 315-319.
Crossref
Crossref
Marina Zemskova, William Wechter, Svetlana Bashkirova, Chien-Shing Chen, Robert Reiter & Michael B. Lilly. (2006) Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase. Biochemical Pharmacology 72:10, pages 1257-1267.
Crossref
Crossref
Heng-Yuan Tang, Ai Shih, H. James Cao, Faith B. Davis, Paul J. Davis & Hung-Yun Lin. (2006) Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Molecular Cancer Therapeutics 5:8, pages 2034-2042.
Crossref
Crossref
ShouWei Han & Jesse Roman. (2006) COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals. Lung Cancer 51:3, pages 283-296.
Crossref
Crossref
Angus G. Dalgleish & Ken O’Byrne. 2006. The Link Between Inflammation and Cancer. The Link Between Inflammation and Cancer
1
38
.
Alvaro C. LagaDani S. ZanderPhilip T. Cagle. (2005) Prognostic Significance of Cyclooxygenase 2 Expression in 259 Cases of Non–Small Cell Lung Cancer. Archives of Pathology & Laboratory Medicine 129:9, pages 1113-1117.
Crossref
Crossref
Jenny T. Mao, Xiaoyan Cui, Karen Reckamp, Ming Liu, Kostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, Saswati Hazra, Robert Strieter, Brian Gardner & Steven M. Dubinett. (2005) Chemoprevention Strategies with Cyclooxygenase-2 Inhibitors for Lung Cancer. Clinical Lung Cancer 7:1, pages 30-39.
Crossref
Crossref
Eduardo Cuesta, Jordi Boada, Jose C. Perales, Teresa Roig & Jordi Bermudez. (2005) Aspirin inhibits NF-?B activation in a glycolysis-depleted lung epithelial cell line. European Journal of Pharmacology 517:3, pages 158-164.
Crossref
Crossref
Eric M. Sievers, Robert D. Bart, Leah M. Backhus, Yuanguang Lin, Margaret Starnes, Roberto Castanos, Vaughn A. Starnes & Ross. M. Bremner. (2005) Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect. The Journal of Thoracic and Cardiovascular Surgery 129:6, pages 1242-1249.
Crossref
Crossref
Sadik A Khuder, Nabeel A Herial, Anand B Mutgi & Douglas J Federman. (2005) Nonsteroidal Antiinflammatory Drug Use and Lung Cancer. Chest 127:3, pages 748-754.
Crossref
Crossref
Alison K. Bauer, Alvin M. Malkinson & Steven R. Kleeberger. (2004) Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. American Journal of Physiology-Lung Cellular and Molecular Physiology 287:4, pages L685-L703.
Crossref
Crossref
Joanne R. Brown & Raymond N. DuBois. (2004) Cyclooxygenase as a Target in Lung Cancer. Clinical Cancer Research 10:12, pages 4266s-4269s.
Crossref
Crossref
Karen Riedl, Kostyantyn Krysan, Mehis Põld, Harnisha Dalwadi, Nathalie Heuze-Vourc’h, Mariam Dohadwala, Ming Liu, Xiaoyan Cui, Robert Figlin, Jenny T Mao, Robert Strieter, Sherven Sharma & Steven M Dubinett. (2004) Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resistance Updates 7:3, pages 169-184.
Crossref
Crossref
Joanne R. Brown & Raymond N. DuBois. (2004) Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention. Chest 125:5, pages 134S-140S.
Crossref
Crossref
D.K. Petkova, C. Clelland, J. Ronan, L. Pang, J.M. Coulson, S. Lewis & A.J. Knox. (2004) Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respiratory Medicine 98:2, pages 164-172.
Crossref
Crossref
R. Stokes Peebles & Koichi Hashimoto. 2004. COX-2 Inhibitors. COX-2 Inhibitors
195
212
.
Gary B. Gordon, Gary J. Kelloff & Caroline C. C. Sigman. 2004. Cancer Chemoprevention. Cancer Chemoprevention
87
105
.
C N Holick, D S Michaud, M F Leitzmann, W C Willett & E Giovannucci. (2003) Aspirin use and lung cancer in men. British Journal of Cancer 89:9, pages 1705-1708.
Crossref
Crossref
J.Esteban Castelao, Robert D BartIIIIII, Costanzo A DiPerna, Eric M Sievers & Ross M Bremner. (2003) Lung cancer and cyclooxygenase-2. The Annals of Thoracic Surgery 76:4, pages 1327-1335.
Crossref
Crossref
Donna O. McCarthy. (2016) Rethinking Nutritional Support for Persons with Cancer Cachexia. Biological Research For Nursing 5:1, pages 3-17.
Crossref
Crossref
Ernest T. Hawk, Jaye L. Viner, Asad Umar, William F. Anderson, Caroline C. Sigman & Kate Z. Guyton. (2003) Cancer and the Cyclo-oxygenase Enzyme. American Journal of Cancer 2:1, pages 27-55.
Crossref
Crossref
Suphat Subongkot, David Frame, William Leslie & Deborah Drajer. (2012) Selective Cyclooxygenase‐2 Inhibition: A Target in Cancer Prevention and Treatment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:1, pages 9-28.
Crossref
Crossref
Deanna Sanchez Yamamoto & Pamela Hallquist Viale. (2003) Cyclooxygenase-2: From Arthritis Treatment to New Indications for the Prevention and Treatment of Cancer. Clinical Journal of Oncology Nursing 7:1, pages 21-29.
Crossref
Crossref
Guido Eibl, Howard A. Reber, Moritz N. Wente & Oscar J. Hines. (2003) The Selective Cyclooxygenase-2 Inhibitor Nimesulide Induces Apoptosis in Pancreatic Cancer Cells Independent of COX-2. Pancreas 26:1, pages 33-41.
Crossref
Crossref
G. J. Kelloff & C. C. Sigman. 2003. Mechanisms in Carcinogenesis and Cancer Prevention. Mechanisms in Carcinogenesis and Cancer Prevention
187
210
.
Tien Hoang, Anne M Traynor & Joan H Schiller. (2002) Novel therapies for lung cancer. Surgical Oncology 11:4, pages 229-241.
Crossref
Crossref
Paul A. BunnJr.Jr. & Robert L. Keith. (2002) The Future of Cyclooxygenase-2 Inhibitors and Other Inhibitors of the Eicosanoid Signal Pathway in the Prevention and Therapy of Lung Cancer. Clinical Lung Cancer 3:4, pages 271-277.
Crossref
Crossref
M. J. Thun, S. J. Henley & C. Patrono. (2002) Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues. JNCI Journal of the National Cancer Institute 94:4, pages 252-266.
Crossref
Crossref
Angus G. Dalgleish & Ken J. O'Byrne. 2002.
231
276
.
Hiroyuki Kohno, Miki Taima, Takashi Sumida, Yoshihiro Azuma, Hiroshi Ogawa & Takuji Tanaka. (2001) Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Letters 174:2, pages 141-150.
Crossref
Crossref
B. L. Upham & J. G. Wagner. (2001) Toxicant-Induced Oxidative Stress in Cancer. Toxicological Sciences 64:1, pages 1-3.
Crossref
Crossref
Y S Bakhle. (2009) COX‐2 and cancer: a new approach to an old problem. British Journal of Pharmacology 134:6, pages 1137-1150.
Crossref
Crossref